(Bloomberg) -- A U.K. biotech company that hopes to study genetic data of residents from an isolated part of Sardinia -- known for having an unusually large number of people who live past 100 -- said it cleared a major legal hurdle last month.

Tiziana Life Sciences Plc expects the victory in Italy to pave the way as it looks for clues about aging and a range of disorders, from a disease known as dry eye to a form of baldness. The company last year purchased the data of almost 13,000 residents in Sardinia from Shardna SpA, a genomics research company, for 258,000 euros ($290,000).

Register or login for access to this item and much more

All Information Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access